V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001809 | 240011596 | 1.63 | 39 | Curative (C) | 2022-04-14 | 2022-04-28 | Triple / Double Intrathecal Therapy + hydrocortisone | N | N | CYTARABINE HIGH DOSE | 100465468 |
| 240001816 | 240011597 | 1.88 | 59.3 | Curative (C) | null | 2020-08-14 | null | null | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101132644 |
| 240001877 | 240011598 | 1.8 | 71.2 | null | null | 2019-10-21 | null | 02 | null | DABRAFENIB | 100172582 |
| 240001895 | 240011601 | 1.7 | 60 | Curative (C) | null | null | null | null | N | VENETOCLAX | 100246995 |
| 240001922 | 240011602 | 1.83 | null | Curative (C) | 2020-01-06 | 2020-03-01 | ALL UKALL2011 Aug BFM Cons C PegAsp | 02 | N | ALL UKALL2011 DEL INT A | 101630483 |
| 240001939 | 240011603 | 1.79 | 80.6 | Curative (C) | 2022-03-21 | 2022-03-27 | null | N | N | VENETOCLAX | 100741940 |
| 240002008 | 240011605 | 1.77 | 91.8 | Palliative (P) | null | 2021-12-26 | CYCLOPHOSPHAMIDE | null | N | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 100372179 |
| 240002063 | 240011610 | 0 | 45.8 | Palliative (P) | 2018-11-13 | 2018-11-20 | CYTARABINE + METHOTREXATE + RITUXIMAB + Hydrocortisone | 02 | N | AML MYECHILD | 100752132 |
| 240002109 | 240011612 | 1.72 | 70.6 | Curative (C) | 2019-06-08 | 2019-07-28 | ALL UKALL2011 Ind B Sht Dex (PAsp) | 02 | N | ANAGRELIDE | 100399769 |
| 240002153 | 240011613 | 1.64 | 20 | Palliative (P) | 2021-09-23 | 2021-10-12 | GEMTUZUMAB OZOGAMICIN | 02 | N | AML DOWNS HAM | 100732469 |
| 240002157 | 240011614 | 1.67 | 31.6 | Curative (C) | 2022-03-08 | 2022-03-16 | DA | 02 | N | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101846235 |
| 240002174 | 240011616 | 1.63 | 85.3 | null | null | 2021-11-09 | TRANSPLANT ATG + FLUDARABINE + THIOTEPA + TREOSULFAN | null | N | CLADRIBINE | 100903268 |
| 240002188 | 240011617 | 1.86 | 32.4 | Curative (C) | 2019-10-18 | 2020-01-28 | AML MyeChild 01 A Mitozantrone/Cytarabine | 01 | null | METHOTREXATE + PEGASPARAGINASE | 100775225 |
| 240002189 | 240011618 | 1.81 | 13.7 | Curative (C) | 2020-06-02 | 2020-06-02 | null | 02 | N | BLEOMYCIN + CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + PROCARBAZINE + VINCRISTINE | 100197632 |
| 240002206 | 240011619 | 1.69 | 54.7 | Curative (C) | 2022-01-21 | 2022-01-29 | null | 02 | null | CYTARABINE + GEMTUZUMAB OZOGAMICIN | 101859904 |
| 240002224 | 240011620 | 1.62 | 53.5 | Curative (C) | 2021-06-23 | 2021-07-14 | METHOTREXATE + PEGASPARGASE | N | N | ALL ALLR3: S/IR CONS | 100606828 |
| 240002241 | 240011621 | 0 | 9.2 | Curative (C) | 2020-11-17 | 2020-11-17 | ESHAP | N | N | ALL UKALL2011 MAINTENANCE | 100540022 |
| 240002248 | 240011622 | 1.67 | 58 | Palliative (P) | 2016-10-15 | 2016-11-20 | DA 3+8 | null | N | IMATINIB | 100581147 |
| 240002282 | 240011623 | 0 | 40.8 | 03 | 2019-12-05 | 2019-12-07 | IBRUTINIB | 02 | null | IBRUTINIB | 101256721 |
| 240002287 | 240011624 | 1.64 | null | null | 2018-07-25 | 2018-07-26 | CVP R | null | null | CNS LOW GRADE GLIOMA VINBLASTINE | 101567333 |
| 240002351 | 240011626 | 1.57 | null | null | 2018-05-25 | 2018-05-25 | ALL UKALL2011 Ind B Sht Dex (PAsp) | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 100578083 |
| 240002374 | 240011627 | 1.6 | 86 | null | 2020-09-18 | 2020-09-21 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | 02 | null | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | 100187681 |
| 240002391 | 240011628 | 1.56 | 90 | null | 2021-06-22 | 2021-06-26 | ALL UKALL2011 Std Int Maint B | 02 | null | BLEOMYCIN + DACARBAZINE + DOXORUBICIN + VINBLASTINE | 101179262 |
| 240002431 | 240011630 | null | 28.95 | Curative (C) | 2020-03-19 | 2020-06-13 | null | 01 | null | FLAIR TRIAL | 101729725 |
| 240002486 | 240011632 | 1.63 | 58.2 | Curative (C) | null | 2022-05-05 | null | null | N | FLAIR TRIAL | 101706950 |
| 240002489 | 240011633 | 1.65 | 63.6 | Disease modification (D) | 2021-06-17 | 2021-08-17 | AML MyeChild 01 Triple IT | 02 | N | CYTARABINE + DAUNORUBICIN | 101869442 |
| 240002577 | 240011634 | 1.65 | null | Curative (C) | 2021-07-21 | 2021-08-08 | FLAIR trial | N | N | TRIPLE INTRATHECAL | 101309020 |
| 240002583 | 240011635 | 0 | 63.7 | null | 2021-11-02 | 2021-11-02 | null | 01 | null | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100560456 |
| 240002610 | 240011636 | 0 | 83.2 | Curative (C) | 2019-12-31 | 2020-01-05 | BUSULFAN | N | null | CYTARABINE + FLUDARABINE + IDARUBICIN | 100238819 |
| 240002619 | 240011637 | 1.85 | 69.7 | null | null | 2019-10-27 | Dasatinib | null | N | IBRUTINIB | 101456528 |
| 240002691 | 240011640 | 1.7 | 41.6 | Palliative (P) | 2021-03-09 | 2021-03-10 | ALL UKALL2011 Maintenance A1 | 02 | null | BUSULFAN | 101090800 |
| 240002722 | 240011642 | 1.58 | 74.9 | Curative (C) | 2018-02-19 | 2018-03-17 | ALL UKALL2011 Ind B Sht Dex (PAsp) | 02 | Y | CHLORAMBUCIL + OBINUTUZUMAB | 100415407 |
| 240002815 | 240011645 | 1.84 | 77 | null | 2020-02-06 | 2020-03-25 | GEMTUZUMAB OZOGAMICIN | 02 | null | EPIRUBICIN + ETOPOSIDE + IFOSFAMIDE | 100137843 |
| 240002845 | 240011646 | 1.5 | 37 | null | 2020-02-19 | 2020-02-21 | LENALIDOMIDE | Y | null | BENDAMUSTINE | 101713235 |
| 240000738 | 240011664 | null | null | null | null | 2018-02-16 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100312022 |
| 240000771 | 240011668 | null | null | null | null | 2016-09-17 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100114324 |
| 240000845 | 240011680 | null | null | null | null | 2018-08-18 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101825179 |
| 240000848 | 240011681 | null | null | null | null | 2018-08-11 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101554888 |
| 240000906 | 240011694 | null | null | null | null | 2020-06-12 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101359772 |
| 240000910 | 240011697 | null | null | null | null | 2019-07-11 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100812971 |
| 240000943 | 240011708 | null | null | Curative (C) | null | 2019-03-12 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101368864 |
| 240000950 | 240011710 | 1.52 | 104 | null | 2020-11-04 | 2020-11-06 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101742824 |
| 240000958 | 240011713 | 0 | 100.5 | null | 2019-12-28 | 2019-12-28 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101507308 |
| 240000960 | 240011714 | null | 12.25 | null | 2017-05-19 | 2017-05-28 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101321769 |
| 240000966 | 240011716 | 1.71 | 77.5 | null | null | 2022-04-28 | null | N | null | BENDAMUSTINE + RITUXIMAB | 101666472 |
| 240000982 | 240011718 | 1.34 | 52.1 | null | null | 2018-07-05 | null | 01 | N | CYTARABINE | 100104477 |
| 240000984 | 240011719 | null | null | null | null | 2021-07-16 | null | N | null | TRIAL UNSPECIFIED | 101342003 |
| 240000988 | 240011720 | 1.7 | 70 | null | null | 2020-04-26 | null | 02 | null | AML18 TRIAL | 100098412 |
| 240000993 | 240011721 | 1.77 | 104.8 | null | null | 2019-08-13 | null | 1 | null | AML18 TRIAL | 101389629 |
| 240000998 | 240011722 | null | null | Palliative (P) | null | 2016-05-29 | AML 18 TRIAL | N | N | HYDROXYCARBAMIDE | 101189260 |